Silent axes swinging in pharmaceutical firms

Published: 2012-08-23 07:00:00

Updated: 2012-08-23 07:00:00

Korean pharmaceutical companies are pushing forward with corporate restructuring as they already feel the pinch of falling sales and profits caused by the government-mandated cuts in drugs prices in April.

Restructuring has not been clamorous in local pharmaceutical sector as most companies do...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK